UBS Says Sunesis Leukemia Pivotal Trial Success 'Likely' By: Benzinga via Benzinga August 27, 2014 at 16:05 PM EDT Sunesis Pharmaceuticals (NASDAQ: SNSS) gained 10 percent Wednesday to near a year high after an analyst said success is "more ... Read More >>